"Most drivers with Alzheimer’s disease will need to stop driving in the middle stage of dementia. Some types of dementia have ...

Around 10 percent of Alzheimer's patients were reported to have a condition that could impact activities such as driving and ...

There are currently no available treatment options for any form of frontotemporal dementia that have been approved by the EMA ...

The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational ...

Robbie's mother Janet is battling with dementia, four years after he revealed his dad Pete has Parkinson's disease ...

Parkinson’s disease is a brain disorder that affects about one million people in the U.S. It happens when the brain loses ...

BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today ...

The Prix Galien USA Best Startup category recognizes outstanding innovation by therapeutics-focused life science companies that have not yet received their first product approval The award to CervoMed ...

Someone with FTD may also notice changes in personality or mood and difficulties with language. Dr. McGrath points out that ...

Wildfire smoke is no longer a one-off event,” said Joan Casey, an environmental epidemiologist. “This is about the health of ...

CervoMed (CRVO) stock rises as FDA grants Orphan Drug Designation for neflamapimod to treat frontotemporal dementia. Read ...

Designation underscores significant unmet need in frontotemporal dementia and the potential role of neflamapimod in multiple neurologic disorders. On track to report topline data ...